55458-82-7

Upstream product

• 64-17-5 ethanol 
• 55458-78-1 2-<4-(2-aminoethyl)phenoxy>-2-methylpropionic acid 
• 1005791-57-0 ethyl 2-[4-(2-azidoethyl)phenoxy]-2-methylpropanate 
• 29655-46-7 N-benzyloxycarbonyl-2-(4-hydroxyphenyl)ethylamine 
• 51-67-2 tyrosamine 
• 144007-70-5 Ethyl 2-[4-(2-carbobenzyloxyamino)ethyl]phenoxy-2-methylpropionate 
• 55458-55-4 ethyl 2-[4-(2-acetaminoethyl)-phenoxy]-2-methyl-propionate 
• 1202-66-0 N-acetyltyramine 

Downstream Products

• 63293-96-9 C₂₃H₂₆ClNO₄ 
• 63346-65-6 C₂₄H₂₉NO₄ 
• 63293-82-3 C₂₃H₂₆FNO₄ 
• 72131-59-0 ethyl 2-{4-[2-(benzenesulphonylamino)-ethyl]-phenoxy}-2-methylpropionate 
• 63293-70-9 C₂₃H₂₆ClNO₄ 
• 63293-94-7 C₂₄H₂₉NO₅ 
• 63293-72-1 C₂₇H₂₉NO₄ 
• 63294-01-9 2-{4-[2-(4-chlorophenylacetamino)-ethyl]-phenoxy}-2-methylpropionic acid 
• 63294-09-7 2-{4-[2-(2-(4-chlorophenoxy)-propionylamino)-ethyl]-phenoxy}-2-methylpropionic acid 
• 63477-52-1 2-{4-[2-(3,5-Di-tert.-butyl-4-hydroxybenzoylamino)-ethyl]-phenoxy}-2-methylpropionic acid 
• 63294-07-5 2-{4-[2-(4-Chlorophenoxyacetamino)-ethyl]-phenoxy}-2-methylpropionic acid 
• 63293-97-0 C₂₁H₂₂ClNO₄ 
• 63293-83-4 C₂₁H₂₂FNO₄ 
• 63293-79-8 2-{4-[2-(2-(4-Chlorophenyl)-2-methylpropionylamino)ethyl]-phenoxy}-2-methylpropionic acid 

Relevant academic research and scientific papers

BETA-3 RECEPTOR LIGANDS AND THEIR USE IN THERAPY

The present invention relates to new compounds, ligands of the beta-3 adrenergic receptor, their preparation and their use in therapy or as research tools for said receptor; the invention also relates to a process for the preparation of the compounds of the invention and the use of inverse agonists of the beta-3 adrenergic receptor as medicaments.

1,2,4-Triazine Derivatives, Preparation and Use Thereof in Human Therapy

The invention concerns 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives of general formula (I), wherein: R1 and R2, identical or different, represent a branched or linear C1-C7 alkyl or alkenyl radical, a C1/s

Phenyl derivatives, their manufacture and use as pharmaceutical agents

This invention relates to compounds of the formula wherein one of R5, R6 and R7 is and X1, X2, Y1 to Y4, R1 to R13 and m and n are defined in the description, and to all enantiomers and pharmaceutically acceptable salts and/or esters thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPARδ and/or PPARα agonists.

Anti-atherosclerotic aryl compounds

The present invention is concerned with compounds of formula (I) STR1 wherein Ar is a mono- or bicyclic aromatic group optionally containing one or two heteroatoms independently selected from nitrogen, oxygen and sulphur, said group being optionally subst